Janssen Showcases Recent Data in Relapsing Multiple Sclerosi

Janssen Showcases Recent Data in Relapsing Multiple Sclerosis at the 2021 European Committee for Treatment and Research in Multiple Sclerosis Congress

Janssen Showcases Recent Data in Relapsing Multiple Sclerosis at the 2021 European Committee for Treatment and Research in Multiple Sclerosis Congress

apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Austria , United States , Vienna , Wien , Jennifer Mcintyre , Bill Martin , Janssen Pharmaceuticals Inc , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , European Union , Research In Multiple Sclerosis , Adelphi Ms Disease Specific Programme , None Of The Janssen Pharmaceutical Companies , European Commission , Actelion Pharmaceuticals Ltd , Exchange Commission , Companies Of Johnson , Idorsia Pharmaceuticals Ltd , Johnson , European Committee For Treatment , Multiple Sclerosis , Global Therapeutic Area Head , Janssen Research , Data Presentations Include , Confirmed Disability Accumulation , Systemic Corticosteroids , Brain Volume Loss , Modifying Treatments , Model Based Meta Analysis , Randomized Clinical Trials , Specific Programme , Brain Volume , Starter Pack , Posterior Reversible Encephalopathy Syndrome , Janssen Pharmaceuticals , Prescribing Information , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Report ,